Paras Healthcare has filed preliminary papers with the market regulator Securities and Exchange Board of India (SEBI) to mobilise Rs 1,800 crore through an initial public offering (IPO). The proposed IPO comprises a fresh issue of equity shares aggregating up to Rs 500 crore and an Offer-For-Sale (OFS) of equity shares worth up to Rs 1,300 crore by the selling shareholder.
The company proposes to utilise the proceeds from the fresh issue towards prepayment or repayment of certain outstanding borrowings, investment in its wholly-owned subsidiary PMHPL for its debt payment, and for general corporate purposes. JM Financial, BofA Securities India and Nuvama Wealth Management are the book-running lead managers to the issue. The shares of the company are proposed to be listed on BSE and NSE.
Paras Healthcare is a clinical specialty-led hospital platform providing tertiary and quaternary healthcare services through a network of eight hospitals with an aggregate capacity of 2,211 beds as of March 31, 2026.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 8487.35 |
| Max Healthcare Inst | 1010.10 |
| Narayana Hrudayalay | 1906.05 |
| Aster DM Healthcare | 812.15 |
| Global Health | 1224.10 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: